Archive: displayed by CME articles

Top

Continuing medical education

Nature Clinical Practice has partnered with Medscape, LLC and Vanderbilt University School of Medicine to provide the opportunity to earn Category 1 AMA PRA Credits™ for selected articles each month. Medscape, LLC and Vanderbilt University School of Medicine are accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other health-care professionals completing any of these activities will be issued a certificate of participation.

There are no fees for participating in or receiving credit for these online educational activities. To complete the questions online and earn continuing medical education credit, you must be a registered user on Medscape.com or have an account in the Vanderbilt CME database.

Medscape logo

If you are not registered on Medscape.com please click on the New Users: Free Registration link on the top left-hand side of the website to register. Registration is free. For questions regarding the content of this activity, contact the accredited provider for this CME activity: cme@medscape.net. For technical assistance, contact cme@webmd.net.

Top

July 2009 Volume 6 No 7

A stepwise approach to the management of metastatic midgut carcinoid tumor

Sanjeev Bhattacharyya, Dorothy M. Gujral, Christos Toumpanakis, Gilles Dreyfus, Brian R. Davidson, Joseph Davar & Martyn E. Caplin

p429 | doi:10.1038/nrclinonc.2009.70

Top

June 2009 Volume 6 No 6

Breast cancer and pregnancy: how safe is trastuzumab?

Hatem A. Azim, Jr, Fedro A. Peccatori, Sarah J. Liptrott, Chiara Catania and Aron Goldhirsch

p367 | doi:10.1038/nrclinonc.2009.48

Top

May 2009 Volume 6 No 5

Cerebral primitive neuroectodermal tumor in an adult with a heterozygous MSH2 mutation

Alexander F. Jeans, Ian Frayling, Bharat Jasani, Lucy Side, Claire Blesing and Olaf Ansorge

p295 | doi:10.1038/nrclinonc.2009.35

Top

April 2009 Volume 6 No 4

Restoration of chemosensitivity by bortezomib: implications for refractory myeloma

Chor Sang Chim, Yu Yan Hwang, Clara Pang & Tony W. Shek

p237 | doi:10.1038/nrclinonc.2009.15

Top

March 2009 Volume 6 No 3

Unintended pregnancy during radiotherapy for cancer

Saskia N de Wildt, Nobuko Taguchi and Gideon Koren

p175 | doi:10.1038/ncponc1320

Top

February 2009 Volume 6 No 2

A case of prolonged disease-free survival in a patient with choroidal metastasis from breast cancer

Raymond W Jang, Mary Doherty, J Jill Hopkins and Ellen Warner

p118 | doi:10.1038/ncponc1294

Top

January 2009 Volume 6 No 1

Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with glioma

Shahriar S Yaghoubi, Michael C Jensen, Nagichettiar Satyamurthy, Shradha Budhiraja, David Paik, Johannes Czernin and Sanjiv S Gambhir

p53 | doi:10.1038/ncponc1278

Top

December 2008 Volume 5 No 12

Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib

Alfonso Quintás-Cardama, Alexander J Lazar, Scott E Woodman, Kevin Kim, Merrick Ross and Patrick Hwu

p737 | doi:10.1038/ncponc1251

Top

November 2008 Volume 5 No 11

Treatment of diffuse large B-cell lymphoma of the liver with yttrium-90 microsphere embolization

Timothy S Fenske, Heather Benjamin, Steven H Kroft, Eric J Hohenwalter and William S Rilling

p677 | doi:10.1038/ncponc1227

Top

October 2008 Volume 5 No 10

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

Vathany Kulasingam and Eleftherios P Diamandis

p588 | doi:10.1038/ncponc1187

Top

September 2008 Volume 5 No 9

CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS

F Stephen Hodi, Darryl A Oble, Jan Drappatz, Elsa F Velazquez, Nikhil Ramaiya, Naren Ramakrishna, Arthur L Day, Andrea Kruse, Suzanne Mac Rae, Axel Hoos and Martin Mihm

p557 | doi:10.1038/ncponc1183

Top

August 2008 Volume 5 No 8

Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy

Scott R Plotkin, Marybeth A Singh, Caroline C O'Donnell, Gordon J Harris, Andrea I McClatchey and Chris Halpin

p487 | doi:10.1038/ncponc1157

Top

July 2008 Volume 5 No 7

Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?

Cristiana Sessa, Aymeric Guibal, Gianluca Del Conte and Curzio Rüegg

p378 | doi:10.1038/ncponc1150

Top

June 2008 Volume 5 No 6

Therapy Insight: anthracyclines and trastuzumab—the optimal management of cardiotoxic side effects

Sanjay Popat and Ian E Smith

p324 | doi:10.1038/ncponc1090

Top

May 2008 Volume 5 No 5

Drug Insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy

Yohann Loriot, Gabriel Perlemuter, David Malka, Frédérique Penault-Lorca, Valérie Boige, Eric Deutsch, Christophe Massard, Jean Pierre Armand and Jean-Charles Soria

p268 | doi:10.1038/ncponc1087

Five donors—one recipient: modeling a mosaic of granulocytes, natural killer and T cells from cord-blood and third-party donors

Björn Schöttker, Tobias Feuchtinger, Michael Schumm, Erdwine Klinker, Rupert Handgretinger, Hermann Einsele and Gernot Stuhler

p291 | doi:10.1038/ncponc1105

Top

April 2008 Volume 5 No 4

Angiogenesis as a strategic target for ovarian cancer therapy

Whitney A Spannuth, Anil K Sood and Robert L Coleman

p194 | doi:10.1038/ncponc1051

Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis

Huy Tran, Catherine Cheung, Devinder Gill, Ujjwal Dua, Jamie Nourse, Richard Boyle and Maher K Gandhi

p250 | doi:10.1038/ncponc1071

Top

Extra navigation

Subscribe

Subscribe to Nature Reviews Clinical Oncology

naturejobs

natureproducts


Advertisement